Modeling hypertrophic IP3 transients in the cardiac myocyte

Biophysical Journal

Volumn 93, Issue 10, 2007, Pages 3421-3433

  Cooling, Michael ^a   Hunter, Peter ^a   Crampin, Edmund J ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CALCINEURIN; CELL PROTEIN; ENDOTHELIN 1; INOSITOL 1,4,5 TRISPHOSPHATE; MEMBRANE RECEPTOR; TRANSCRIPTION FACTOR NFAT;

ARTICLE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; MATHEMATICAL MODEL; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SIMULATION;

EID: 36549069357     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.107.110031     Document Type: Article

References (53)

1. Heineke, J., and J. D. Molkentin. 2006. Regulation of cardiac hypertrophy by intracellular signaling pathways. Nat. Rev. Mol. Cell Biol. 7:589-600.
2. Molkentin, J. D., J.-R. Lu, C. L. Antos, B. Markham, J. Richardson, J. Robbins, S. R. Grant, and E. N. Olson. 1998. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93:215-228.
3. Sugden, P. H. 1999. Signaling in myocardial hypertrophy: life after calcineurin? Circ. Res. 84:633-646.
4. Bare, D. J., C. S. Kettlun, M. Liang, D. M. Bers, and G. A. Mignery. 2005. Cardiac type 2 inositol 1,4,5-trisphosphate receptor: interaction and modulation by calcium/calmodulin-dependent protein kinase II. J. Biol. Chem. 280:15912-15920.
5. Hardt, S. E., and J. Sadoshima. 2002. Glycogen synthase kinase-3β: a novel regulator of cardiac hypertrophy and development. Circ. Res. 90:1055-1063.
6. Yamazaki, T., and Y. Yazaki. 2000. Molecular basis of cardiac hypertrophy. Zeitschrift fr. Kardiologie. 89:1-6.
7. Passier, R., H. Zeng, N. Frey, F. J. Naya, R. L. Nicol, T. A. McKinsey, P. Overbeek, J. A. Richardson, S. R. Grant, and E. N. Olson. 2000. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Invest. 105:1395-1406.
8. Wilkins, B. J., and J. D. Molkentin. 2002. Calcineurin and cardiac hypertrophy: where have we been? Where are we going? J. Physiol. (Lond.). 541:1-8.
9. Kohno, M., and J. Pouyssegur. 2003. Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs. Prog. Cell Cycle Res. 5:219-224.
10. 2+, calcineurin, and NFAT. Cell. 96:611-614.
11. Ju, H., S. Zhao, P. S. Tappia, V. Panagia, and I. M. C. Dixon. 1998. Expression of Gqα and PLC-β in scar and border tissue in heart failure due to myocardial infarction. Circulation. 97:892-899.
12. q class of G-proteins. Nature. 350:516-518.
13. Wilkins, B. J., and J. D. Molkentin. 2004. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem. Biophys. Res. Commun. 322:1178-1191.
14. Crabtree, G. R., and E. N. Olson. 2002. NFAT signaling: choreographing the social lives of cells. Cell. 109:S67-S79.
15. Leinwand, L. A. 2001. Calcineurin inhibition and cardiac hypertrophy: a matter of balance. Proc. Natl. Acad. Sci. USA. 98:2947-2949.
16. Crampin, E. J., M. Halstead, P. Hunter, P. Nielsen, D. Noble, N. Smith, and M. Tawhai. 2004. Computational physiology and the physiome project. Exp. Physiol. 89:1-26.
17. Kakita, T., K. Hasegawa, E. Iwai-Kanai, S. Adachi, T. Morimoto, H. Wada, T. Kawamura, T. Yanazume, and S. Sasayama. 2001. Calcineurin pathway is required for Endothelin-1-mediated protection against oxidant stress-induced apoptosis in cardiac myocytes. Circ. Res. 88:1239-1246.
18. Sadoshima, J., Y. Xu, H. S. Stayter, and S. Izumo. 1993. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 75:977-984.
19. Lijnen, P., and V. Petrov. 1999. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. J. Mol. Cell. Cardiol. 31:949-970.
20. Goutsouliak, V., and S. W. Rabkin. 1998. Comparison of angiotensin II type-1 and type-2 receptor antagonists on angiotensin II-induced IP3 generation in cardiomyocytes. Gen. Pharmacol. 30:367-372.
21. Touyz, R., and C. Berry. 2002. Recent advances in angiotensin II signaling. Braz. J. Med. Biol. Res. 35:1001-1015.
22. αq/11, phospholipase Cβ3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor. Chin. Med. J. 117:88-93.
23. Mehta, P. K., and K. K. Griendling. 2007. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell Physiol. 292:C82-C97.
24. Lloyd, C. M., M. D. B. Halstead, and P. F. Nielsen. 2004. CellML: its future, present and past. Prog. Biophys. Mol. Biol. 85:433-450.
25. Lukas, T. J. 2004. A signal transduction pathway model prototype I: from agonist to cellular endpoint. Biophys. J. 87:1406-1416.
26. Shea, L., and J. J. Linderman. 1997. Mechanistic model of G-protein signal transduction determinants of efficacy and effect of precoupled receptors. Biochem. Pharmacol. 53:519-530.
27. Freedman, N. J., A. S. Ament, M. Oppermann, R. H. Stoffel, S. T. Exum, and R. J. Lefkowitz. 1997. Phosphorylation and desensitization of human endothelin A and B receptors. Evidence for G-protein-coupled receptor kinase specificity. J. Biol. Chem. 272:17734-17743.
28. Bers, D. M. 2002. Excitation-Contraction Coupling and Cardiac Contractile Force, 2nd Ed. Kluwer Academic Publishers, New York.
29. Hunton, D. L., L.-Y. Zou, Y. Pang, and R. B. Marchase. 2004. Adult rat cardiomyocytes exhibit capacitative calcium entry. Am. J. Physiol. Heart Circ. Physiol. 286:H1124-H1132.
30. Haugh, J. M., A. Wells, and D. A. Lauffenburger. 2000. Mathematical modeling of epidermal growth factor receptor signaling through the phospholipase C pathway: mechanistic insights and predictions for molecular interventions. Biotechnol. Bioeng. 70:225-238.
31. Willars, G. B., S. R. Nahorski, and R. A. Challiss. 1998. Differential regulation of muscarinic acetylcholine receptor-sensitive polyphosphoinositide pools and consequences for signaling in human neuroblastoma cells. J. Biol. Chem. 273:5037-5046.
32. Remus, T. P., A. V. Zima, J. Bossuyt, D. J. Bare, J. L. Martin, L. A. Blatter, D. M. Bers, and G. A. Mignery. 2006. Biosensors to measure inositol 1,4,5-trisphosphate concentration in living cells with spatiotemporal resolution. J. Biol. Chem. 281:608-616.
33. Takanashi, M., and M. Endoh. 1992. Concentration- and time-dependence of phosphoinositide hydrolysis induced by endothelin-1 in relation to the positive inotropic effect in the rabbit ventricular myocardium. J. Pharmacol. Exp. Ther. 262:1189-1194.
34. Parkinson, P. A., H. Parfenova, and C. W. Leffler. 2000. Phospholipase C activation by prostacyclin receptor agonist in cerebral microvascular smooth muscle cells. Proc. Soc. Exp. Biol. Med. 223:53-58.
35. Morris, M. D. 1991. Factorial sampling plans for preliminary computational experiments. Technometrics. 33:161-174.
36. Campolongo, F., S. Tarantola, and A. Saltelli. 1999. Tackling quantitatively large dimensionality problems. Comput. Phys. Commun. 117:75-85.
37. Campolongo, F., J. Cariboni, A. Saltelli, and W. Schoutens. 2004. Enhancing the Morris Method. In Sensitivity Analysis of Model Output. K. M. Hanson, and F. M. Hemez, editors. SAMO 2004, Santa Fe, New Mexico.
38. Saltelli, A., S. Tarantola, F. Campolongo, and M. Ratto. 2004. Sensitivity Analysis in Practice - A Guide to Assessing Scientific Models. Wiley, New York.
39. Abdellatif, M. M., C. D. Neubauer, W. J. Lederer, and T. B. Rogers. 1991. Angiotensin-induced desensitization of the phosphoinositide pathway in cardiac cells occurs at the level of the receptor. Circ. Res. 69:800-809.
40. Jiang, T., E. Pak, H. Zhang, R. P. Kline, and S. F. Steinberg. 1996. Endothelin-dependent actions in cultured AT-1 cardiac myocytes: the role of the R isoform of protein kinase C. Circ. Res. 78:724-736.
41. Hairer, E., and G. Wanner. 1996. Solving ordinary differential equations. II. Stiff and differential-algebraic problems. In Springer Series in Computational Mathematics, Vol. 14, 2nd Ed. Springer, New York.
42. Cramer, H., W. Muller-Esterl, and C. Schroeder. 1997. Subtype-specific desensitization of human endothelin ETA and ETB receptors reflects differential receptor phosphorylation. Biochemistry. 36:13325-13332.
43. Sadoshima, J., and S. Izumo. 1993. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro. Roles of phospholipid-derived second messengers. Circ. Res. 73:424-438.
44. Ferguson, S. S. G., J. Zhang, L. S. Barak, and M. G. Caron. 1998. Molecular mechanisms of G-protein-coupled receptor desensitization and resensitization. Life Sci. 62:1561-1565.
45. Bremnes, T., J. D. Paasche, A. Mehlum, C. Sandberg, B. Bremnes, and H. Attramadal. 2000. Regulation and intracellular trafficking pathways of the endothelin receptors. J. Biol. Chem. 275:17596-17604.
46. Innamorati, G., C. Le Gouill, M. Balamotis, and M. Birnbaumer. 2001. The long and the short cycle. alternative intracellular routes for trafficking of G-protein-coupled receptors. J. Biol. Chem. 276:13096-13103.
47. Noble, D., and Y. Rudy. 2001. Models of cardiac ventricular action potentials: iterative interaction between experiment and simulation. Philos. Trans. Roy. Soc. London A Math. Phys. Eng. Sci. 359:1127-1142.
48. Crampin, E. J., and N. Smith. 2005. A dynamic model of excitation-contraction coupling during acidosis in cardiac ventricular myocytes. Biophys. J. 90:3074-3090.
49. Bhalla, U. S., and R. Iyengar. 1999. Emergent properties of networks of biological signaling pathways. Science. 283:381-387.
50. Sivakumaran, S., S. Hariharaputran, J. Mishra, and U. S. Bhalla. 2003. The database of quantitative cellular signaling: management and analysis of chemical kinetic models of signaling networks. Bioinformatics. 19:408-415.
51. Xu, C., J. Watras, and L. M. Loew. 2003. Kinetic analysis of receptor-activated phosphoinositide turnover. J. Cell Biol. 161:779-791.
52. Leri, A., S. Franco, A. Zacheo, L. Barlucchi, S. Chimenti, F. Limana, B. Nadal-Ginard, J. Kajstura, P. Anversa, and M. Blasco. 2003. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J. 22:131-139.
53. Kobayashi, T., T. Miyauchi, S. Sakai, M. Kobayashi, I. Yamaguchi, K. Goto, and Y. Sugishita. 1999. Expression of endothelin-1, ETA and ETB receptors, and ECE and distribution of endothelin-1 in failing rat heart. Am. J. Physiol. Heart Circ. Physiol. 276:H1197-H1206.